Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial-Reference-Cited by-同舟云学术

Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial

Published:2024-02 Issue:2 Volume:25 Page:246-254
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bajpai Jyoti,Kapu Venkatesh,Rath Sushmita,Kumar Sravan,Sekar Anbarasan,Patil Priyanka,Siddiqui Altaf,Anne Srikanth,Pawar Akash,Srinivas Sujay,Bhargava Prabhat,Gulia Seema,Noronha Vanita,Joshi Amit,Prabhash Kumar,Banavali Shripad,Sarin Rajiv,Badwe Rajendra,Gupta Sudeep

Publisher

Elsevier BV

Reference30 articles.

1. Proposal for classifying the acute emetogenicity of cancer chemotherapy;Hesketh;J Clin Oncol,1997

2. Decreased binding affinity of olanzapine and clozapine for human muscarinic receptors in intact clonal cells in physiological medium;Bymaster;Eur J Pharmacol,2000

3. Review of olanzapine in the management of bipolar disorders;Narasimhan;Neuropsychiatr Dis Treat,2007

4. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding;Schotte;Psychopharmacology (Berl),1996

5. Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer;Srivastava;J Pain Symptom Manage,2003

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial;Journal of Clinical Oncology;2024-09-06

3. A randomized, double-blind, placebo-controlled phase II study of olanzapine based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B);Annals of Oncology;2024-09

4. Comparison of olanzapine 2.5 mg and 5 mg in the prevention of chemotherapy-induced nausea and vomiting: a Japanese nationwide database study;International Journal of Clinical Oncology;2024-08-18

5. Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis;Frontiers in Oncology;2024-07-26